As I sit down to write this, we’re in the middle of a virtual lockdown across much of the country, some ordered by local governments and some voluntarily undertaken to avoid the spread of a new virus wreaking havoc across the globe. I hope that by the time you read this, the global pandemic that has upended lives around the world will be abating and that the actions we took individually and collectively will make a difference both in the outcomes of the pandemic and in the future of so many that will be affected by the time this is over. What I have been most struck with, aside from actions taken by state and local governments, is the way sports franchises, entertainment companies, corporations large and small, and, of course, the airlines, have voluntarily taken drastic steps to mitigate the spread of this virus. I hope this signals a new willingness in other areas to consider the public good along with self-preservation.
I’m thinking about another epidemic that has implications for pilots, especially general aviation pilots who aren’t required to hold a medical, that we could do more about collectively as an industry. And that is the use of drugs that can compromise safety when flying. I’ve just finished reading the recent NTSB report on the prevalence of drugs found in toxicology reports of flying pilots who died in aircraft accidents. The report covers fatal accidents in the United States over the five-year period from 2013 to 2017. During this time, there were 1,042 aviation accidents in which the flying pilot was fatally injured. Toxicology reports were available for 952 pilots (91 percent). Those reports found that “266 (28 percent) fatally injured pilots tested positive for at least one potentially impairing drug, 144 (15 percent) pilots tested positive for at least one drug indicating a potentially impairing condition, 94 (10 percent) pilots’ test results indicated evidence of use of at least one controlled substance, and 47 (5 percent) tested positive for an illicit drug.”